Larson Financial Group LLC Annovis Bio, Inc. Transaction History
Larson Financial Group LLC
- $2.7 Billion
- Q3 2025
A detailed history of Larson Financial Group LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 300 shares of ANVS stock, worth $693. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$693
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ANVS
# of Institutions
50Shares Held
2.04MCall Options Held
167KPut Options Held
97.2K-
Vanguard Group Inc Valley Forge, PA738KShares$1.7 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA218KShares$504,5520.0% of portfolio
-
Geode Capital Management, LLC Boston, MA184KShares$425,3950.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il174KShares$402,7360.0% of portfolio
-
Northern Trust Corp Chicago, IL121KShares$279,6480.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $18.9M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...